Inventor · disambiguated record
Anatole Klyosov
Also filed as: KLYOSOV ANATOLE · KLYOSOV ANATOLE A
28 granted patents·8 pending applications·563 citations·filing 1997–2022
97Inventor score
Files withGALECTIN THERAPEUTICS INC14PRO PHARMACEUTICALS INC7THERMO FIBERGEN INC5PLATT DAVID2TRABER PETER G2
Top patents by PatentIndex Score
36 records- 0196US8236780B2Galactose—pronged polysaccharides in a formulation for antifibrotic therapiesPLATT DAVID·Filed 2007·Granted Aug 7, 2012·39 cites·3 claims
- 0295US8962824B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2014·Granted Feb 24, 2015·11 cites·30 claims
- 0394US7893252B2Selectively depolymerized galactomannan polysaccharidePRO PHARMACEUTICALS INC·Filed 2008·Granted Feb 22, 2011·27 cites·12 claims
- 0491US6156226ALiquid and solid de-icing and anti-icing compositions and methods for making sameTHERMO FIBERGEN INC·Filed 1999·Granted Dec 5, 2000·113 cites·14 claims
- 0589US8871925B2Compositions of novel carbohydrate drug for treatment of human diseasesZOMER ELIEZER·Filed 2012·Granted Oct 28, 2014·13 cites·21 claims
- 0689US8722645B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesPLATT DAVID·Filed 2012·Granted May 13, 2014·8 cites·14 claims
- 0788US9974802B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2017·Granted May 22, 2018·4 cites·13 claims
- 0888US8658787B2Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver diseaseTRABER PETER G·Filed 2012·Granted Feb 25, 2014·15 cites·44 claims
- 0986US10420793B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·1 cites·17 claims
- 1086US9649327B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2014·Granted May 16, 2017·5 cites·19 claims
- 1186US5876505AMethod of producing glucose from papermaking sludge using concentrated or dilute acid hydrolysisTHERMO FIBERGEN INC·Filed 1998·Granted Mar 2, 1999·60 cites·21 claims
- 1285US6642205B2Methods and compositions for reducing side effects in chemotherapeutic treatmentsPRO PHARMACEUTICALS INC·Filed 2001·Granted Nov 4, 2003·15 cites·29 claims
- 1385US5777086AMethod of recovering lignin from pulp and paper sludgeTHERMO FIBERGEN INC·Filed 1997·Granted Jul 7, 1998·51 cites·15 claims
- 1484US9200090B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2012·Granted Dec 1, 2015·4 cites·9 claims
- 1584US7012068B2Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancerPRO PHARMACEUTICALS INC·Filed 2002·Granted Mar 14, 2006·16 cites·25 claims
- 1684US6758996B2Cellulose-reinforced thermoplastic composite and methods of making sameKADANT COMPOSITES INC·Filed 2001·Granted Jul 6, 2004·67 cites·20 claims
- 1784US6645946B1Delivery of a therapeutic agent in a formulation for reduced toxicityPRO PHARMACEUTICALS INC·Filed 2001·Granted Nov 11, 2003·17 cites·16 claims
- 1883US9872909B2Method for enhancing specific immunotherapies in cancer treatmentTRABER PETER G·Filed 2013·Granted Jan 23, 2018·10 cites·17 claims
- 1983US5961941AProduction of precipitated calcium carbonate from papermaking sludge and sludge-derived ashTHERMO FIBERGEN INC·Filed 1997·Granted Oct 5, 1999·31 cites·13 claims
- 2082US6914055B2Delivery of a therapeutic agent in a formulation for reduced toxicityFiled 2003·Granted Jul 5, 2005·12 cites·10 claims
- 2182US2023000898A1Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2279US10799525B2Composition of novel carbohydrate drug for treatment of human diseasesGALECTIN THERAPEUTICS INC·Filed 2019·Granted Oct 13, 2020·0 cites·18 claims
- 2379US10398778B2Method for enhancing specific immunotherapies in cancer treatmentGALECTIN THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·3 cites·19 claims
- 2476US11413303B2Methods for treatment of arthritisGALECTIN THERAPEUTICS INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 2575US6982255B2Delivery of a therapeutic agent in a formulation for reduced toxicityKLYOSOV ANATOLE·Filed 2003·Granted Jan 3, 2006·12 cites·7 claims
- 2674US8367638B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2011·Granted Feb 5, 2013·1 cites·9 claims
- 2773US9763974B2Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthaseGALECTIN THERAPEUTICS INC·Filed 2013·Granted Sep 19, 2017·2 cites·14 claims
- 2873US5919424AMethod of recovering minerals from papermaking sludge and sludge-derived ashTHERMO FIBERGEN INC·Filed 1997·Granted Jul 6, 1999·26 cites·27 claims
- 2973US2021008097A1Compositions Comprising Galactose-Pronged PolysaccharidesGALECTIN THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3066US10744154B2Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2017·Granted Aug 18, 2020·0 cites·17 claims
- 3159US2016058785A1Galactose-pronged polysaccharides in a formulation for antifibrotic therapiesGALECTIN THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 3258US2003229028A1Methods and compositions for reducing side effects in chemotherapeutic treatmentsFiled 2003·Application pending·0 cites
- 3358US2011077217A1Selectively depolymerized galactomannan polysaccharidePRO PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3455US2005043272A1Compositions and methods for hydrophobic drug deliveryPRO PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 3550US2005239743A1Compositions and methods to inhibit restenosisPRO PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 3639US2007258969A1Compositions and methods for targeting metastatic tumors using multivalent ligand-linked carbohydrate polymersZOMER ELIEZER·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →